SN
Shah Nikita
Président Exécutif
OtherF
Historial del iniciado
Director GeneralTodavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Browse the full record of transactions filed by Shah Nikita, Président Exécutif. Officer active across 1 company, notably Amneal Pharmaceuticals, Inc.. Cumulatively, 21 reports have been published. Split: 0 buy · 7 sells. Total volume traded: €5.2m. Activity tracked since 15 December 2021. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Shah Nikita
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones21 en total
146.403 títulos@ 17,51 US$Class A Common StockSEC:0001628280-26-056757:0
36.232 títulosClass A Common StockSEC:0001628280-26-015235:0
36.331 títulos@ 2,75 US$2.8% de su flujoClass A Common StockSEC:0001628280-25-052413:0
114.492 títulos@ 9,66 US$31.9% de su flujoClass A Common StockSEC:0001738061-25-000004:0
71.694 títulos@ 9,29 US$28.1% de su flujoClass A Common StockSEC:0001723128-25-000052:0
50.000 títulos@ 9,04 US$26.5% de su flujoClass A Common StockSEC:0001723128-25-000050:0
49.140 títulos@ 7,58 US$30.7% de su flujoClass A Common StockSEC:0001628280-25-026513:0
36.232 títulosClass A Common StockSEC:0001628280-25-010678:0
28.958 títulosClass A Common StockSEC:0001628280-25-010113:0
100.000 títulos@ 7,75 US$65.0% de su flujoClass A Common StockSEC:0001628280-24-037557:0
28.957 títulosClass A Common StockSEC:0001628280-24-008945:0
35.620 títulosClass A Common StockSEC:0001628280-24-007994:0
36.232 títulosClass A Common StockSEC:0001209191-23-016934:0
18.064 títulos@ 1,92 US$3.0% de su flujoClass A Common StockSEC:0001209191-23-016934:1
11.729 títulosClass A Common StockSEC:0001209191-23-015519:0
35.620 títulosClass A Common StockSEC:0001209191-23-014120:0
4442 títulosClass A Common StockSEC:0001209191-22-028163:0
11.728 títulosClass A Common StockSEC:0001209191-22-016055:0
35.620 títulosClass A Common StockSEC:0001209191-22-014142:0
2000 títulos@ 3,95 US$0.2% de su flujoClass A Common StockSEC:0001209191-21-070257:0
4441 títulosClass A Common StockSEC:0001209191-21-031566:0
About Shah Nikita
Shah Nikita is Président Exécutif and Executive Vice President at Amneal Pharmaceuticals, Inc. He has 20 filings in total, and across the 20 sampled filings from 2021-05-11 to 2026-03-05, the reported transactions are exclusively sales, for a total of EUR 2954599, with the dominant transaction nature stated as Levée d'options.